News | Radiation Therapy | October 03, 2017

ASTRO Awards Early-Career Research Grants to Physician-Scientists

Radiation oncology society announces $275,000 in grants to four researchers

ASTRO Awards Early-Career Research Grants to Physician-Scientists

October 3, 2017 — The American Society for Radiation Oncology (ASTRO) awarded $275,000 in research awards to four early-career scientists as part of the Society’s efforts to retain and foster the intellectual research talent currently entering the field of radiation oncology. For 2017, the Research Grants committee selected one Junior Faculty Award and three Resident Seed Grant recipients. All winners were recognized at ASTRO’s 59th Annual Meeting, taking place Sept. 24-27 in San Diego.

“ASTRO may not conduct its own scientific research — but we aim to create an environment where researchers are able to succeed. These grants recognize the innovative work being done by those in our field, and they also identify and encourage early-career researchers,” said ASTRO Chair David C. Beyer, M.D., FASTRO. “By supporting these researchers, our specialty will benefit from their discoveries, which, in turn, will eventually lead to better outcomes for our patients — the ultimate goal we physicians strive for, every day.”

The ASTRO Junior Faculty Career Research Training Award (JFA) gives early-career physicians and researchers the opportunity to develop careers and focus on research relevant to radiation oncology, biology or physics. Recipients must be board-eligible physicians, physicists in radiation oncology or radiobiologists within the first three years of their junior faculty appointment. One junior faculty member was selected for this award, which provides $100,000 annually for two years.

  The 2017 JFA grant recipient is Erina Vlashi, Ph.D., from the University of California Los Angeles (UCLA). Vlashi is interested in how ionizing radiation (IR) induces the reprogramming of breast cancer cells into breast-cancer-initiating or stem cells that can lead to increased tumor growth and treatment resistance. Understanding the steps in how radiation alters the metabolic state of breast tumor cells can provide key insights into how these cells will respond to subsequent IR exposure.

The ASTRO Resident/Fellows in Radiation Oncology Research Seed Award supports residents or fellows who are planning a career in basic science or clinical research in radiation oncology. Three researchers were selected for this award, which provides $25,000 per recipient for one year. The three 2017 Resident/Fellows in Radiation Oncology Research Seed Award recipients are:

  • Devarati Mitra, M.D., Ph.D., from the Dana-Farber Cancer Institute, Boston. Mitra will investigate how administration of hypofractionated radiation modulates the immune response in head and neck carcinoma. He will explore if such modulation can increase the efficacy of immune checkpoint inhibitors when combined with radiation;
  • Shushan Rana, M.D., from the Oregon Health & Science University, Portland, Ore. Rana will investigate how microRNA, specifically miR-15a, affects endothelial radiosensitivity through regulation of acid sphingomyelinase ceramide-induced apoptosis, a pathway which is preferentially induced at higher doses of radiation. He hopes to ultimately prevent the development of immune cell anergy and/or exhaustion to improve tumor responses to anti-tumor treatment; and
  • Ye Yuan, M.D., from UCLA. Yuan’s interest is in how tumors evade the immune system through upregulation of PD-L1 and PD-L2 expression. Mediators that inhibit gene expression including micro-RNA molecules can be activated by radiation treatment. How radiation activates miR-34 that subsequently binds to and downregulates PD-L1 and PD-L2 expression still remains unclear and may be an effective way to stimulate the immune response to kill tumor cells.

All awardees must submit a report to ASTRO at the midterm and the conclusion of their research, and they are strongly encouraged to submit their study as an abstract to a subsequent ASTRO Annual Meeting. The grant winners are selected by ASTRO’s Research Grants Evaluation Committee within the Science Council and approved by the ASTRO Board of Directors.

For more information:

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor


News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...